Durham, United Kingdom

Stuart Cockerill


 

Average Co-Inventor Count = 1.3

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2019-2022

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: An Overview of Inventor Stuart Cockerill

Introduction

Stuart Cockerill is an innovative inventor based in Durham, GB, known for his contributions to the field of pharmaceuticals. With a strong academic background and hands-on experience, Cockerill has made significant strides in creating compounds that address microbial infections.

Latest Patents

Cockerill holds two notable patents that highlight his expertise in antiviral and antimicrobial compounds. The first patent, "Antiviral Benzodiazepine Compounds," relates to specific compounds that have potential pharmaceutical applications. This invention focuses on methods for synthesizing these compounds, which are designed to treat, ameliorate, or prevent microbial infections. The second patent, "Antimicrobial Compound," similarly addresses compounds of formula (I) and details methods of synthesis and therapeutic usage for combating microbial infections. Both inventions showcase Cockerill's commitment to advancing healthcare solutions through innovative chemistry.

Career Highlights

Stuart Cockerill is affiliated with the University of Durham, enhancing the institution's research capabilities in medicinal chemistry. His ability to bridge theoretical knowledge with practical applications ensures that his inventions contribute meaningfully to society, particularly in public health.

Collaborations

Cockerill collaborates with Jonathan Harburn, furthering research endeavors that lead to groundbreaking discoveries. Their joint efforts exemplify the importance of teamwork in the pursuit of innovation in the pharmaceutical sciences.

Conclusion

In conclusion, Stuart Cockerill is a prominent inventor whose work is shaping the future of pharmaceuticals with his patents focusing on antiviral and antimicrobial compounds. His dedication to research and collaboration within the University of Durham reinforces the vital role that academic institutions play in fostering innovation and developing new treatment options for microbial infections.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…